Physician profile
Omar Ali
NPI 1972527059
$6,536.25
in general payments reported to CMS, 2019-2025
19 companies · $520 in 2025
The $520 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,762 · 2020: $391 · 2021: $337 · 2022: $210 · 2023: $662 · 2024: $1,654 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,827 · Travel and Lodging: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,827.39 |
| Travel and Lodging | $1,008.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,351.09 | 2019-2025 | Mitraclip, Jot Dx, Navitor |
| Medtronic, INC. | $592.04 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Boston Scientific Corporation | $450.34 | 2019-2023 | Watchman Access System |
| Edwards Lifesciences Corporation | $178.44 | 2020-2025 | Evoque |
| Abiomed | $145.60 | 2019 | |
| Livanova USA, INC. | $141.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $111.30 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $103.65 | 2019-2020 | |
| Amgen INC. | $89.95 | 2019 | |
| Medtronic Vascular, INC. | $79.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $74.62 | 2019 | |
| Pfizer INC. | $60.82 | 2020-2025 | |
| Amarin Pharma, INC. | $44.95 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.69 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $15.44 | 2023 | Diamondback Peripheral |
| Vifor Pharma, INC. | $13.99 | 2019 | |
| Tactile Systems Technology INC | $13.86 | 2019 | |
| Dentsply Sirona INC | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.